Abstract
Vascularized composite allotransplantation (VCA) has emerged as a viable clinical procedure in the past decade. The immunology of VCA remains to be fully investigated and holds much promise to impact the larger field of solid organ transplantation. The initial data suggest that the rate of acute cellular rejection following VCA is higher than seen in solid organs. Yet, the majority of these events are amenable to early diagnosis and completely reversible with timely intervention. Surprisingly, the incidence of chronic rejection in VCA appears to be lower than seen in solid organs. This and other aspects including the role of humoral immunity, ischemia-reperfusion injury, and the significance of donor hematopoietic tissue in VCA grafts will need further study to improve our understanding of VCA. This chapter briefly discusses our current understanding of immunological aspects of VCA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353:1315–20.
Murray JE. The first successful organ transplants in man. J Am Coll Surg. 2005;200:5–9.
Gibson T, Medawar PB. The fate of skin homografts in man. J Anat. 1943;77:299–310 4.
Moseley RV, Sheil AG, Mitchell RM, Murray JE. Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation. 1966;4:678–87.
Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg. 1971;47:425–31.
Guild WR, Harrison JH, Merrill JP, Murray J. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc. 1955;67:167–73.
Brent L, Medawar PB. Tissue transplantation: a new approach to the “typing” problem. Br Med J.1963;2:269–72.
Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87:401–11.
Black KS, Hewitt CW, Fraser LA, et al. Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine. Transplantation. 1985;39:365–8.
Benichou G, Yamada Y, Yun SH, Lin C, Fray M, Tocco G. Immune recognition and rejection of allogeneic skin grafts. Immunotherapy. 2011;3:757–70.
Hautz T, Wolfram D, Grahammer J, et al. Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation. Clin Dev Immunol. 2012;2012:757310.
von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. New Eng J Med. 2000;343:1020–34.
Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15–26.
Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury–a fresh look. Exp Mol Pathol. 2003;74:86–93.
Dulkanchainun TS, Goss JA, Imagawa DK, et al. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg. 1998;227:832–40.
Busuttil RW, Lipshutz GS, Kupiec-Weglinski JW, et al. rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. Am J Transplant. 2011;11:786–97.
Hautz T, Zelger B, Grahammer J, et al. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant. 2010;10:1200–9.
Bejarano PA, Levi D, Nassiri M, et al. The Pathology of full-thickness cadaver skin transplant for large abdominal defects: a proposed grading system for skin allograft acute rejection. Am J Surg Pathol. 2004;28:670–5.
Kanitakis J, Petruzzo P, Jullien D, et al. Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. Eur J Dermatol. 2005;15:235–8.
Cendales LC, Kirk AD, Moresi JM, Ruiz P, Kleiner DE. Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation. 2006;81:418–22.
Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8:1396–400.
Schneeberger S, Gorantla VS, van Riet RP, et al. Atypical acute rejection after hand transplantation. Am J Transplant. 2008;8:688–96.
Cendales LC, Kirk AD, Moresi JM, Ruiz P, Kleiner DE. Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation. 2005;80:1676–80.
Hautz T, Brandacher G, Zelger B, et al. Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts. Transplant Proc. 2009;41:509–12.
Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med.1969;280:735–9.
Patel R, Glassock R, Terasaki PI. Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. JAMA. 1969;207:1319–24.
Gebel HM, Liwski RS, Bray RA. Technical aspects of HLA antibody testing. Curr Opin Organ Transplant. 2013;18:455–62.
Gloor J, Stegall MD. Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol. 2010;6:297–306.
Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol 2009;162:1–12.
Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet. 2013;381:313–9.
Taner T, Gandhi MJ, Sanderson SO, et al. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant. 2012;12:1504–10.
Ravindra KV, Buell JF, Kaufman CL, et al. Hand transplantation in the United States: experience with 3 patients. Surgery. 2008;144:638–43; discussion 43–4.
Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013;257:345–51.
Wu S, Xu H, Chen B, et al. Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Transplantation. 2011;92:627–33.
Kaufman CL, Ouseph R, Blair B, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant. 2012;12:1004–16.
Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (ʻCAN’). Am J Transplant. 2007;7:518–26.
Kanitakis J, McGregor B, Badet L, et al. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation. 2007;84:265–7.
Landin L, Cavadas PC, Ibanez J, Roger I, Vera-Sempere F. CD3 + -mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation. 2009;87:776–81.
Reibke R, Garbi N, Ganss R, Hammerling GJ, Arnold B, Oelert T. CD8 + regulatory T cells generated by neonatal recognition of peripheral self-antigen. Proc Natl Acad Sci U S A. 2006;103:15142–7.
Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med. 2000;6:782–9.
Haribhai D, Lin W, Relland LM, Truong N, Williams CB, Chatila TA. Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol. 2007;178:2961–72.
Monteiro M, Almeida CF, Caridade M, et al. Identification of regulatory Foxp3 + invariant NKT cells induced by TGF-beta. J Immunol. 2010;185:2157–63.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.
Safinia N, Leech J, Hernandez-Fuentes M, Lechler R, Lombardi G. Promoting transplantation tolerance; adoptive regulatory T cell therapy. Clin Exp Immunol. 2013;172:158–68.
Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD4 + CD25 + regulatory T cells promote experimental transplantation tolerance. Blood. 2007;109:827–35.
Eljaafari A, Badet L, Kanitakis J, et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation. 2006;82:1764–8.
Hewitt CW, Black KS, Dowdy SF, et al. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation. 1986;41:39–43.
Granger DK, Briedenbach WC, Pidwell DJ, Jones JW, Baxter-Lowe LA, Kaufman CL. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation. 2002;74:1624–30.
Thaunat O, Badet L, El-Jaafari A, Kanitakis J, Dubernard JM, Morelon E. Composite tissue allograft extends a helping hand to transplant immunologists. Am J Transplant. 2006;6:2238–42.
Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med. 2012;4:124ra28.
Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. New Eng J Med. 2008;358:353–61.
Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant. 2012;12:1133–45.
Pascual J, Perez-Saez MJ, Mir M, Crespo M. Chronic renal allograft injury: early detection, accurate diagnosis and management. Transplant Rev. 2012;26:280–90.
Petruzzo P, Lanzetta M, Dubernard JM, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation. 2010;90:1590–4.
Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation. 2012;93:855–9.
Unadkat JV, Schneeberger S, Horibe EH, et al. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant. 2010;10:251–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ravindra, K. (2015). Unique Immunological Features of Vascularized Composite Allografts. In: Brandacher, G. (eds) The Science of Reconstructive Transplantation. Stem Cell Biology and Regenerative Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2071-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2071-6_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2070-9
Online ISBN: 978-1-4939-2071-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)